Chicago emerging as a life science and biopharma hub

17-May-2021 - Last updated on 17-May-2021 at 13:26 GMT

Many turn to Boston and North Carolina’s Research Triangle to set up life science companies, but Chicago is now also fast becoming a draw in this respect. The city is emerging as a life science and biopharma hub and seems poised for even further growth, in CGT in particular.

In fact, in recent times, tens of billions of dollars have flooded into the Midwest to accelerate life sciences innovation, and Illinois is ranked in the top 10 states in funding from the US National Institutes of Health.

In the second episode of our newly launched broadcast series, The BioPharma Hub, I am joined by two eminent industry professionals who call Chicago home.

They provide a deep dive into the windy city's standing in the life science space.

Anshul Mangal, is president of Project Farma - a consulting firm providing biomanufacturing strategy and execution and alongside that role he is president of Precision ADVANCE. He pioneered the industrialization of two FDA-approved cell and gene therapies.

Also chatting to us is Tony Khoury, executive vice president, Project Farma. Khoury is a life sciences industry veteran, with vast experience in biologics and advanced therapies.

Tune in to hear more.